Evidence map›Paper›PMID 36429192›Full record

ArticleFoods (Basel, Switzerland)2022

Overcoming Anxiety Disorder by Probiotic

Guanlan Liu, Israr Khan, Yuxi Li, Yun Yang, Xuerui Lu, Yafei Wang, Junxiang Li, Chunjiang Zhang

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Lanzhou Lily (Food science & nutrition · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Nutrients · 2024
    Article
  8. Foods (Basel, Switzerland) · 2024
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Guanlan LiuSchool of Life Sciences, Lanzhou University, Lanzhou 730000, China.
Israr KhanSchool of Life Sciences, Lanzhou University, Lanzhou 730000, China.
Yuxi LiSchool of Life Sciences, Lanzhou University, Lanzhou 730000, China.
Yun YangSchool of Pharmacy, Lanzhou University, Lanzhou 730000, China.
Xuerui LuSchool of Pharmacy, Lanzhou University, Lanzhou 730000, China.
Yafei WangSchool of Pharmacy, Lanzhou University, Lanzhou 730000, China.
Junxiang LiSchool of Pharmacy, Lanzhou University, Lanzhou 730000, China.
Chunjiang ZhangSchool of Life Sciences, Lanzhou University, Lanzhou 730000, China.
Lanzhou University · CN

Funding

Gansu Province Science and technology plan project - Key R & D Plan 18YF1FA044Gansu Province Science and technology plan project - Key R & D Plan 21YF5FA105the Key Project of NMPA Key Laboratory for Quality Control of Traditional Chinese Medicine 2020GSMPA-KL11
6 · The paper itself

Abstract

Lactiplantibacillus plantarum LZU-J-TSL6 with high γ-aminobutyric acid (GABA) production (3.838 g/L) was screened and isolated from the Chinese fermented food snack “Jiangshui”. The improvement effect on anxiety disorder was explored using mice as animal models. In vitro results revealed that LZU-J-TSL6 had the potential to colonize the intestine (p < 0.01) and the anxiety-like behavior of the mice after seven days’ gavage with LZU-J-TSL6 was significantly improved (p < 0.01) when compared to the model group. LZU-J-TSL6 was able to effectively increase the GABA content in the mice hippocampus (p < 0.0001) and restore some markers related to anxiety such as brain-derived neurotrophic factor (BDNF), glial fibrillary acidic protein (GFAP), and 5-hydroxytryptamine (5-HT). Simultaneously, it had a certain repair effect on Nissl bodies and colon tissue in mice hippocampus. In addition, LZU-J-TSL6 increased the relative abundance of beneficial bacteria Bacteroides and Muribaculum, thereby regulating the imbalance of intestinal microbiota caused by anxiety disorder. It also affects the nerve pathway and intestinal mucosal barrier by increasing the content of glutamine and γ-aminobutyric acid and other related metabolites, thereby improving anxiety. Therefore, the GABA-producing Lactobacillus plantus LZU-J-TSL6 can be used as a probiotic to exert an indirect or direct anti-anxiety effect by maintaining the balance of the intestinal environment, producing related metabolites that affect nerve pathways and repair the intestinal mucosal barrier. It can be used as an adjuvant treatment to improve anxiety disorders.

Indexed as

anxietyGABAgut microbiotaintestinal mucosal barrierLactiplantibacillus plantarum

Identifiers

PMID36429192
PMCPMC9689226
OpenAlexW4309013030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.